z-logo
open-access-imgOpen Access
High-Dose Statins Should Be Used in All Acute Ischemic Strokes
Author(s) -
Majaz Moonis
Publication year - 2012
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.633354
Subject(s) - medicine , cardiology , stroke (engine) , ischemic stroke , acute stroke , statin , ischemia , tissue plasminogen activator , mechanical engineering , engineering
This case raises several questions: (1) Is the role for statins in acute ischemic stroke to improve outcome, to reduce the chances of a recurrent stroke, or both? (2) Do the benefits associated with high dose statin use extend across all stroke sub-types including catheter related stroke?Irrespective of the etiology of ischemic stroke, use of statins has been associated with reduced infarct size and a more favorable outcome.1 This is reinforced by our own observations that statins given within 4 weeks of stroke onset improve stroke outcome at 90 days compared with subjects not given statins. The benefits were more pronounced in statin-na|fkve patients who received statins early on after the stroke as compared with patients on statins before stroke onset. Furthermore, the benefits extended across all stroke types including cardioembolic stroke.2,3Similarly, using the Kaiser Permanente …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom